Galderma Laboratories, L.P. et al v. Apotex Inc. et al
| Galderma Laboratories, L.P. and TCD Royalty Sub LP |
| Apotex Inc. and Apotex Corp. |
| 1:2022cv00724 |
| June 2, 2022 |
| US District Court for the District of Delaware |
| Stephanos Bibas |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 6, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 68 NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Filing 67 NOTICE OF SERVICE of Apotex's Objections to Plaintiffs' 30(b)(6) Deposition Notice to Apotex filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) |
| Filing 66 NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Admission (Nos. 1-21); and (2) Plaintiffs' Second Set of Interrogatories to Apotex Inc. and Apotex Corp. filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Filing 65 NOTICE to Take Deposition of Chirag Shah on November 29, 2023 filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Filing 64 NOTICE to Take Deposition of Kiran Krishnan on November 27, 2023 filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Filing 63 NOTICE to Take Deposition of Navin Vaya on November 20, 2023 filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Filing 62 NOTICE to Take Deposition of Bhupesh Singh on November 17, 2023 filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
Filing 61
ORAL ORDER: I DENY the parties' stipulation to modify schedule (D.I. #60 ). As I said previously, I will not look kindly on further requests for extensions and require good cause to justify any such requests. I see no good cause here. Ordered by Judge Stephanos Bibas on 11/1/2023. (smg)
|
| Filing 60 STIPULATION and [Proposed] Order to Modify Schedule by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
| Filing 59 NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Claim Chart filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Filing 58 NOTICE of 30(b)(6) Deposition of Plaintiffs Galderma Laboratories L.P. and TCD Royalty Sub LP by Apotex Corp., Apotex Inc. (Hitch, Cortlan) |
| Filing 57 NOTICE to Take Deposition of Niraj Shah filed by Apotex Corp., Apotex Inc..(Hitch, Cortlan) |
| Filing 56 NOTICE to Take Deposition of Rong-Kun Chang filed by Apotex Corp., Apotex Inc..(Hitch, Cortlan) |
| Filing 55 NOTICE to Take Deposition of Arash Raoufinia filed by Apotex Corp., Apotex Inc..(Hitch, Cortlan) |
| Filing 54 NOTICE OF SERVICE of Plaintiffs' Notice of Deposition of Apotex Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Filing 53 Joint STATUS REPORT by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
|
Filing 52
SO ORDERED, re #51 STIPULATION TO EXTEND TIME for the parties to file an interim status report pursuant to paragraph 16 of the Scheduling Order to September 6, 2023. Signed by Judge Stephanos Bibas on 9/1/2023. (twk)
|
| Filing 51 STIPULATION TO EXTEND TIME for the parties to file an interim status report pursuant to paragraph 16 of the Scheduling Order to September 6, 2023 - filed by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
| Filing 50 NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-14) and (2) Plaintiffs' Objections and Responses to Defendants' Request for Production of Documents and Things (Nos. 1-40) filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Filing 49 NOTICE OF SERVICE of Apotex's Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-7) filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) |
| Filing 48 NOTICE OF SERVICE of (1) Apotex's First Set of Interrogatories (Nos. 1-14); and (2) Apotex's First Set of Requests for Production (Nos. 1-40) filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) |
|
Filing 47
SO ORDERED, re #46 MOTION for Pro Hac Vice Appearance of Attorney Christopher B. Prescott filed by Apotex Inc., Apotex Corp. Ordered by Judge Stephanos Bibas on 7/13/2023. (mpb)
|
| Filing 46 MOTION for Pro Hac Vice Appearance of Attorney Christopher B. Prescott - filed by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) |
| Filing 45 NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Apotex Inc. and Apotex Corp. filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
|
Filing 44
SO ORDERED, regarding D.I. #43 Stipulation filed by TCD Royalty Sub LP, Galderma Laboratories, L.P. Signed by Judge Stephanos Bibas on 6/23/2023. (apk)
|
| Filing 43 STIPULATION Regarding Claim Construction [Corrected] re #42 Stipulation by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
| Filing 42 STIPULATION Regarding Claim Construction by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
|
Filing 41
SO ORDERED, regarding D.I. #40 STIPULATION TO EXTEND TIME for Certain Claim Construction Deadlines to Various Dates (Claim Construction Opening Brief due by 7/7/2023., Claim Construction Answering Brief due by 7/28/2023., Claim Construction Reply Brief due by 8/11/2023., Claim Construction Sur-Reply Brief due by 8/21/2023., Joint Claim Construction Brief due by 8/24/2023.) Signed by Judge Stephanos Bibas on 6/12/2023. (apk)
|
| Filing 40 STIPULATION TO EXTEND TIME for Certain Claim Construction Deadlines to Various Dates - filed by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
| Filing 39 NOTICE OF SERVICE of Plaintiffs' Identification of Claim Terms for Construction filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Filing 38 NOTICE OF SERVICE of Apotex's Responses to Plaintiffs' First Set of Requests for Production (Nos. 1-121) filed by Apotex Corp., Apotex Inc..(Hitch, Cortlan) |
| Filing 37 NOTICE OF SERVICE of INITIAL INVALIDITY CONTENTIONS filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) |
|
Filing 36
SO ORDERED, regarding D.I. #35 STIPULATION TO EXTEND TIME for Defendants Apotex Inc. and Apotex Corp. to serve Initial Invalidity Contentions to May 19, 2023 (Notice of Compliance deadline set for 5/19/2023.) Signed by Judge Stephanos Bibas on 5/12/2023. (apk)
|
| Filing 35 STIPULATION TO EXTEND TIME for Defendants Apotex Inc. and Apotex Corp. to serve Initial Invalidity Contentions to May 19, 2023 - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) |
| Filing 34 NOTICE OF SERVICE of Plaintiffs' Initial Infringement Claim Chart filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Filing 33 NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Filing 32 NOTICE OF SERVICE of Apotex's Production of Core Technical Documents filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) |
|
Filing 31
SO ORDERED, regarding D.I. #28 Proposed Order filed by TCD Royalty Sub LP, Galderma Laboratories, L.P., and D.I. #27 Proposed Order filed by TCD Royalty Sub LP, Galderma Laboratories, L.P. Signed by Judge Stephanos Bibas on 03/27/2023. (apk)
|
| Filing 30 NOTICE OF SERVICE of Apotex's Paragraph 3 Disclosures filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) |
| Filing 29 NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Filing 28 PROPOSED ORDER -- [Proposed] Stipulated Order Regarding Discovery, Including Discovery of Electronically Stored Information ("ESI") -- by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
| Filing 27 PROPOSED ORDER -- [Proposed] Stipulated Protective Order -- by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
| Filing 26 NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents and (2) Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Filing 25 NOTICE OF SERVICE of Apotex's Rule 26(a)(1) Initial Disclosures filed by Apotex Corp., Apotex Inc..(Hitch, Cortlan) |
|
Filing 24
SCHEDULING ORDER: Joinder of Parties due by 9/1/2023. Amended Pleadings due by 9/1/2023. Discovery due by 12/1/2023. Opening Expert Reports due by 1/19/2024. Rebuttal Expert Reports due by 2/23/2024. Expert Discovery due by 3/29/2023. Status Report due by 9/1/2023. Claim Construction Opening Brief due by 6/30/2023. Claim Construction Answering Brief due by 7/21/2023. Claim Construction Reply Brief due by 8/4/2023. Claim Construction Surreply Brief due by 8/14/2023. Joint Claim Construction Brief due by 8/17/2023. Proposed Pretrial Order due by 5/17/2024.(See Order for further details) Signed by Judge Stephanos Bibas on 03/13/2023. (smg)
|
| Filing 23 Joint PROPOSED ORDER -- [Proposed] Scheduling Order -- (with disputed provisions) re 22 Oral Order by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
|
Filing 22
ORAL ORDER, I ORDER the parties to submit a proposed scheduling order by March 10, 2023, at 5 p.m. eastern time. Ordered by Judge Stephanos Bibas on 3/1/2023. (twk)
|
| Filing 21 Joint Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan regarding Joint Status Report - re 20 Oral Order,. (Tigan, Jeremy) |
|
Filing 20
ORAL ORDER: I ORDER the parties to confer and submit a joint status report, not to exceed three single-spaced pages, by February 28, 2023, at 5 p.m. eastern time. The report shall discuss Galderma Laboratories L.P. v. Lupin Inc., 1:21-cv-01710-SB, as well as the need for a scheduling conference and scheduling order. Ordered by Judge Stephanos Bibas on 02/21/2023. Associated Cases: 1:22-cv-00724-SB, 1:22-cv-01166-SB, 1:22-cv-01312-SB(smg)
|
| Filing 19 NOTICE of Change of Firm Affiliation by Galderma Laboratories, L.P., TCD Royalty Sub LP (Tigan, Jeremy) |
| Filing 18 NOTICE requesting Clerk to remove Evan D. Diamond, Vanessa Y. Yen, and the law firm of King & Spalding LLP as co-counsel.. (Tigan, Jeremy) |
| Filing 17 NOTICE of Change of Firm Affiliation by Galderma Laboratories, L.P., TCD Royalty Sub LP (Blumenfeld, Jack) |
| Filing 16 ANSWER to #13 Answer to Complaint, Counterclaim by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Pro Hac Vice Attorney Lance A. Soderstrom, Deepro R. Mukerjee, and Joseph M. Janusz for Apotex Corp. and Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
|
Filing 15
ORDER granting #9 MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Janusz, Attorney Deepro R. Mukerjee, and Attorney Lance A. Soderstrom. Signed by Judge Stephanos Bibas on 6/23/2022. (srs)
|
| Filing 14 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceutical Holdings, Inc. for Apotex Inc.; Corporate Parent Aposherm Delaware Holdings Corporation for Apotex Corp. filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) |
| Filing 13 ANSWER to #1 Complaint , COUNTERCLAIM against Apotex Corp., Apotex Inc. by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) |
|
Filing 12
ORDER granting #11 MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Evan D. Diamond, Vanessa Y. Yen and Andrew J. Cochran. Signed by Judge Stephanos Bibas on 6/23/2022. (nmg)
|
| Pro Hac Vice Attorney Gerald J. Flattmann, Jr, Evan D. Diamond, Andrew J. Cochran, and Vanessa Y. Yen for Galderma Laboratories, L.P. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Evan D. Diamond, Vanessa Y. Yen and Andrew J. Cochran - filed by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
|
Filing 10
ORDER: DESIGNATION OF CIRCUIT JUDGE TO HOLD A DISTRICT COURT WITHIN THE CIRCUIT, designating and assigning the Honorable Stephanos Bibas of the United States Court of Appeals for the Third Circuit. Signed by Judge Michael A Chagares, Chief Judge of the United States Court of Appeals for the Third Circuit on 6/9/2022. (rjb)
|
| Case Assigned to Judge Stephanos Bibas of the United States Court of Appeals for the Third Circuit. Please include the initials of the Judge (SB) after the case number on all documents filed. (rjb) |
| Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Janusz, Attorney Deepro R. Mukerjee, and Attorney Lance A. Soderstrom - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) |
| Filing 8 SUMMONS Returned Executed by TCD Royalty Sub LP, Galderma Laboratories, L.P.. Apotex Corp. served on 6/2/2022, answer due 6/23/2022. (Tigan, Jeremy) |
| Filing 7 Summons Issued as to Apotex Corp. on 6/2/2022. (twk) |
| Filing 6 Summons Issued as to Apotex Inc. on 6/2/2022. (twk) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Galderma Services Inc. for Galderma Laboratories, L.P.; Corporate Parents Drug Royalty III LP 2, DRI Healthcare Trust for TCD Royalty Sub LP - filed by Galderma Laboratories, L.P., TCD Royalty Sub LP. (twk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,749,532 B2; 8,206,740 B2. (twk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about April 20, 2022. Date of Expiration of Patent: December 24, 2025 (U.S. Patent No. 8,206,740), December 19, 2027 (U.S. Patent No. 7,749,532). Thirty Month Stay Deadline: 10/20/2024. (twk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Filing 1 COMPLAINT filed against Apotex Corp., Apotex Inc. ( Filing fee $ 402, receipt number ADEDC-3887209.) - filed by TCD Royalty Sub LP, Galderma Laboratories, L.P.. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(twk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
